<乌鸦传媒>Just How Bad Is a 'Sulfur Microbial Diet' for Colorectal Cancer Risk? Risk for CRC increased by 27% in healthcare workers who consumed the highest amounts Nov 12, 2021
<乌鸦传媒>T-Cell Therapy Shows Promise in Rare Sarcomas Afami-cel induced durable responses in synovial sarcoma and myxoid/round cell liposarcoma Nov 12, 2021
<乌鸦传媒>Preterm Birth Drug Tied to Cancer Risk in Those Exposed in Utero Mothers who took 17-OHPC for miscarriage in the 1950s and 1960s had offspring at greater risk Nov 12, 2021
<乌鸦传媒>High COVID Complication Rates in Sarcoma Patients Half of patients in registry-based study were hospitalized Nov 12, 2021
<乌鸦传媒>Ripretinib Continues to Demonstrate Benefit in Advanced GIST Updated analysis shows stable PFS, improved OS Nov 11, 2021
<乌鸦传媒>Is Multiple Myeloma a Greater Threat to Black Patients? Incidence and treatment disparities combined with a heightened COVID risk is cause for concern Nov 11, 2021
<乌鸦传媒>A Gentler Standard for Acute Promyelocytic Leukemia in Kids ATRA/arsenic trioxide without maintenance therapy resulted in 99-100% survival at 2 years Nov 11, 2021
<乌鸦传媒>Rare Case of Multiple Myeloma in Teenage Girl Successful use of affordable induction therapy with autologous stem cell transplantation Nov 09, 2021
<乌鸦传媒>Vaccinated Blood Cancer Patients Still at Risk for Severe COVID-19 Those with hematologic malignancies also remain at higher risk of mortality as well Nov 08, 2021
<乌鸦传媒>Investigational Oral CKD-Anemia Agent Effective, Safe HIF-PHI daprodustat increased hemoglobin without hurting heart Nov 05, 2021
<乌鸦传媒>Benzene Found in Spray Deodorants Now Too, Valisure Says Online pharmacy has previously petitioned FDA regarding contaminated hand sanitizers, sunscreens Nov 05, 2021
<乌鸦传媒>Ibrutinib Boosts Survival in Younger Patients With Certain DLBCL Subtypes New analysis "casts the PHOENIX trial in a new light," authors say Nov 04, 2021
<乌鸦传媒>Tumor Volume-Adapted RT Leads to Good Lung Cancer Control With Low Toxicity No recurrence at 1 year in 90% of cases with primary tumors, metastases, synchronous disease Nov 02, 2021
<乌鸦传媒>FDA Approves STAMP Inhibitor for Chronic Myeloid Leukemia Patients treated with two or more TKIs and those with T315I mutation gain new option Nov 01, 2021
<乌鸦传媒>Primary RT Fares Well in Abbreviated Trial for HPV Oropharyngeal Cancer No deaths, progression with RT after early termination because of deaths in surgery arm Oct 29, 2021
<乌鸦传媒>Pathologists Consider 'Workaround' So Patients Don't Freak Out Over EHR Bad News Doctors worry patients will misconstrue language or be psychologically harmed without guidance Oct 28, 2021
<乌鸦传媒>Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancer No survival benefit, but risk of biochemical failure, metastasis, cancer death improved Oct 28, 2021
<乌鸦传媒>Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancer Prolonged adjuvant ADT also improved survival Oct 27, 2021
<乌鸦传媒>Extended-Field RT Boosts Survival in Locally Advanced Cervical Cancer Double-digit improvements in OS, DFS, extrapelvic control in well-selected patients Oct 27, 2021
<乌鸦传媒>Gentler Adjuvant RT Could Be Viable for Some HPV-Positive Oral Cancers Those with extranodal extension didn't fare as well Oct 27, 2021
<乌鸦传媒>Gene Test Finds Gradations in High-Risk Prostate Cancer Study of untreated cancers prognostic for metastasis, cancer mortality, overall survival Oct 26, 2021
<乌鸦传媒>Low-Quality Mammography Leading to More Deaths in Black Women, Says Expert In cities like Chicago, Black women face higher breast cancer mortality versus white women Oct 26, 2021
<乌鸦传媒>No Survival Benefit for Internal Mammary Node Irradiation in Breast Cancer Women with medially or centrally located tumors may be candidates, however, says researcher Oct 26, 2021
<乌鸦传媒>Potential New Standard for Post-Prostatectomy Radiotherapy Side effects at 2 years similar with hypofractionated versus conventional RT Oct 25, 2021
<乌鸦传媒>Targeted RT Boosts PFS in Oligoprogressive Lung Cancer Fivefold improvement in NSCLC but no benefit in oligoprogressive breast cancer Oct 25, 2021
<乌鸦传媒>Two Mechanically Assisted Colonoscopy Devices Square Off Randomized trial revealed one found more and larger adenomas Oct 25, 2021
<乌鸦传媒>More Evidence for Safety of Accelerated Radiation in Early Breast Cancer Studies show low toxicity with few recurrences Oct 25, 2021
<乌鸦传媒>Cognitive Therapy Boosts Penile Injection Compliance Post-Prostatectomy Men became more comfortable with treatment to ward off ED, study suggests Oct 25, 2021
<乌鸦传媒>Benefits of Post-Op Penile Traction Therapy Hold Up Over Time Improvements in length, function seen at 9 months after prostatectomy Oct 23, 2021
<乌鸦传媒>Myeloma Drug Pulled From Market Just Months After Approval Data from confirmatory trial failed to make a compelling case for full FDA approval Oct 22, 2021
<乌鸦传媒>Cabozantinib Shows Activity Against RCC Brain Metastases Retrospective study reported intracranial responses in about one half of patients Oct 22, 2021
<乌鸦传媒>Rare Aggressive Bladder Cancer Treated Successfully in Elderly Man Neoadjuvant chemotherapy followed by cystectomy achieves complete response Oct 21, 2021
<乌鸦传媒>Analysis Confirms Benefits of CDK4/6 Inhibition in Early Breast Cancer Reduced risk of recurrence, distant relapse with adjuvant abemaciclib Oct 20, 2021
<乌鸦传媒>'Modest' Link Between Infertility and Postmenopausal Breast Cancer Study finds increased risk for younger women, those with primary infertility Oct 19, 2021
<乌鸦传媒>'You're Still Doing WHAT After Lung Cancer Surgery?!' But don't give up on hardened smokers, researcher urges Oct 19, 2021
<乌鸦传媒>A Better Option for Preserving Fertility in Gynecologic Cancer Patients? In vitro maturation can result in both embryos and oocyte vitrification, researcher says Oct 19, 2021
<乌鸦传媒>The Price Tag of FDA's 'Onco-Exceptionalism' Substantial use of certain cancer drugs without an overall survival benefit Oct 18, 2021
<乌鸦传媒>Abiraterone Active in Androgen Receptor-Positive Salivary Tumors Disease control in 62.5% of a small cohort, including five partial responses Oct 14, 2021
<乌鸦传媒>Newly Approved EGFR Drug Yields Meaningful Benefit in Rare NSCLCs Oral tyrosine kinase inhibitor may serve patient population with high unmet need Oct 14, 2021
<乌鸦传媒>First CDK4/6 Inhibitor OK'd for Early, High-Risk Breast Cancer Abemaciclib approved with endocrine therapy for hormone receptor-positive/HER2-negative disease Oct 13, 2021
